, , , , , , , , ,

SerenQ HGH Fragment 176-191 15mg Peptide Pen

£105.00

SerenQ HGH Fragment 176-191 15mg Peptide Pen

A new name in research peptides, landing in the UK

SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done.

SerenQ has appointed The Ped Shop as its exclusive UK stockist. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

SerenQ Pharmaceuticals

SerenQ HGH Fragment 176-191 15mg Peptide Pen

Peptide Injection Pen System

15mg
ContentHGH Fragment 176-191 15mg
Dial graduation10u = 500mcg
Per unit50mcg
Total units300u
FormatPre-filled pen
Pen tips32G 0.23 x 4mm
Expiry12/2027
AuthenticityQR + serial

Composition & Dosing Guide

HGH Fragment 176-191 15mg · 3 ml pen · 300 units

Total volume
3 ml
Total liquid in the pen
Total contents
15 mg
HGH Frag 176-191 in the pen
Dosing scale
0.01 ml = 1 unit
Each unit on the pen dial equals 0.01 ml
Concentration
5.00 mg/ml
HGH Frag 176-191 per millilitre
Dosing examples
Units Volume (ml) HGH Frag 176-191 (mg)
2 units 0.02 ml 0.10 mg
4 units 0.04 ml 0.20 mg
6 units 0.06 ml 0.30 mg
8 units 0.08 ml 0.40 mg
10 units 0.10 ml 0.50 mg
12 units 0.12 ml 0.60 mg
14 units 0.14 ml 0.70 mg
16 units 0.16 ml 0.80 mg
18 units 0.18 ml 0.90 mg
20 units 0.20 ml 1.00 mg
300 units 3.00 ml (full pen) 15.00 mg (total)
Key example
10 units = 0.10 ml, the pen’s dial graduation, containing 0.50 mg HGH Frag 176-191.
Figures are the pen’s stated contents divided across its 300 units. For research purposes only. Not for human consumption. SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen

Third Party Testing

Results pending

Every SerenQ batch is sent for independent analysis before it goes on general sale. Purity and identity testing for this batch is currently with Analiza, and the certificate will be published on this page the moment it lands.

LaboratoryAnaliza
TestPurity & identity
MethodHPLC / MS
StatusAwaiting report

Check back here for the full certificate, or ask us and we will send it over as soon as it is released.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag. SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen SerenQ HGH Fragment 176-191 15mg Peptide Pen

You can verify your SerenQ authenticity and view the latest HPLC at
auth.seren-q.com

 

About HGH Fragment 176-191

HGH Fragment 176-191 is the last 16 amino acids of the growth hormone molecule, isolated on the basis that the fat metabolising activity of GH appears to sit in that region of the chain while the growth promoting activity sits elsewhere.

The premise is straightforward: if the lipolytic and the anabolic effects of growth hormone can be separated by using only part of the molecule, then the fragment should influence fat metabolism without raising IGF-1, without the glucose effects that follow GH administration, and without the growth signalling. Animal work in the 1990s and early 2000s supported that separation reasonably well.

Human evidence is where it becomes complicated. AOD-9604, a modified version of this same fragment, was taken into human trials by an Australian company and failed to produce meaningful weight loss against placebo in a phase IIb study. That result is the single most important piece of evidence about this fragment, and it is not a favourable one. It is worth knowing before choosing it over a GLP-1.

Where the evidence sits: the animal data on this fragment is reasonably consistent, but the human trial programme on its closest relative did not replicate it. This is a compound where the preclinical story and the clinical result disagree, and the clinical result is the one that counts. It holds no medicines licence.

The pen format

Fragment protocols in the literature are frequent, small and timed around fasted periods, which makes a dial far more practical than reconstituting and drawing. 15mg gives 30 full 500mcg draws.

  • 15.00mg of HGH Frag 176-191 per pen, in solution and ready to use
  • 1 unit = 50mcg. 10 units on the dial gives 500mcg
  • 300 units in total, which works out at 30 full 500mcg draws per pen
  • Dial and dose window let you set the exact amount and read it back before dispensing
  • 4 screw on pen tips supplied, individually sealed, 32G 0.23 x 4mm
  • Protective cap, clip and a rigid retail carton for storage and transport
  • Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

  • Store refrigerated at 2 to 8°C. Do not freeze
  • Keep in the outer carton, away from direct light
  • Short periods at room temperature during transit are expected and normal
  • Use a fresh sealed tip for each dispense and dispose of tips in a sharps container
  • Expiry 12/2027 on sealed, correctly stored stock
  • Keep out of reach of children and animals

What is in the box

  • 1 × SerenQ HGH Fragment 176-191 15mg pre-filled injection pen
  • 4 × sealed pen tips, 32G 0.23 x 4mm
  • Serialised, QR coded retail carton

Choosing between the Fragment, AOD-9604 and a GLP-1

AOD-9604 is this same fragment with a tyrosine added to stabilise it, and it is the version that actually went through human trials. If you want the better characterised of the two, it is AOD. If you want more material for the money, the fragment pen carries three times the peptide of a 5mg AOD vial.

The harder comparison is against a GLP-1. Tirzepatide and retatrutide have large human trials behind them showing substantial weight loss; the fragment has an animal literature and a failed phase IIb. Anyone choosing the fragment for fat loss should do so knowing that the evidence gap between the two is not marginal, it is the whole thing.

Guides that go deeper:

For research purposes only

This product is sold strictly as a laboratory research chemical. It is not a medicine, not a supplement and not a cosmetic. It is not for human or veterinary consumption, and it is not intended to diagnose, treat, cure or prevent any disease or condition.

HGH Fragment 176-191 is not licensed as a medicinal product by the MHRA, the FDA or any other regulator. Nothing on this page should be read as medical advice, a recommendation, or a suggestion of use in humans or animals.

By purchasing you confirm you are 18 or over, that you are acquiring this product for legitimate laboratory research or analytical use only, and that you accept full responsibility for its safe handling, storage and lawful use under the regulations that apply where you are.
SerenQ HGH Fragment 176-191 15mg Peptide PenSerenQ HGH Fragment 176-191 15mg Peptide PenSerenQ HGH Fragment 176-191 15mg Peptide Pen

Shopping Cart